Company intelligence / Profile preview

Labio

Ansan-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Labio is a South Korean biotechnology company specializing in the development of bio-active ingredients for the cosmetics and personal care industries. The company leverages advanced fermentation, bioconversion, and plant cell culture technologies to produce high-performance ingredients such as fermented oils, pseudo-ceramides, and plant-derived exosomes. Labio's R&D focus includes skin barrier restoration, anti-aging, and anti-inflammatory solutions. The company operates as a key supplier to global cosmetic brands and continues to expand its portfolio into health supplements and potentially pharmaceutical applications.

Therapeutic areas: ImmunologyDermatology
Modalities: Small moleculePeptidesExosome-based therapy
Industry: Non-Drug Biotech

Partnerships

AmorePacificLG Household & Health Care

Beyond the preview

Go deeper on Labio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labio.

Explore the full profile